An optimized method to differentiate HL60 cells into neutrophil-like cells
Journal of Leukocyte Biology · 2026
DOI: 10.1093/jleuko/qiag081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2026. Verfasst von Samuel P Collie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Biology Program, University of Michigan Medical School, 1135 Catherine St., Ann Arbor, MI 48109, USA. Hauptthemen laut MEDLINE: Neutrophils, Cell Differentiation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Michigan School of Medicine, American Heart Association, National Institute of Health.
Abstract (Originalsprache)
The HL60 promyelocytic leukemia cell line is widely used to investigate neutrophil biology due to its genetic tractability and accessibility. HL60 cells can be differentiated into neutrophil-like cells using all-trans retinoic acid (ATRA) or dimethyl sulfoxide (DMSO) treatment. However, these approaches produce cells that lack critical features of mature granulocytes, such as robust chemotaxis with ATRA treatment or multilobed nuclear morphology with DMSO treatment. To overcome these limitations, we developed a sequential differentiation protocol—ATRA for 1 d followed by DMSO for 4 d (A1D4)—which yields neutrophil-like cells that more faithfully recapitulate the morphology and functionality of mature human neutrophils. A1D4-differentiated HL60 cells display segmented nuclei with low lamin A/C expression and demonstrate strong chemotactic, oxidative burst, and phagocytic activity. This protocol combines the advantages of treatment with the individual compounds, producing cells that closely mimic primary human neutrophils in both phenotype and function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cellular and Molecular Biology Program, University of Michigan Medical School, 1135 Catherine St., Ann Arbor, MI 48109, USA.
- College of Literature, Science, and Arts, University of Michigan, 500 S State St., Ann Arbor, MI 48109, USA.
- Life Sciences Institute, University of Michigan, 210 Washtenaw Ave., Ann Arbor, MI 48109, USA.
- Department of Pharmacology, University of Michigan School of Medicine, 1150 W Medical Center Dr., Ann Arbor, MI 48109, USA.
- Department of Cell & Developmental Biology, University of Michigan School of Medicine, 109 Zina Pitcher Pl., Ann Arbor, MI 48109, USA.
- Rogel Cancer Center, University of Michigan School of Medicine, 1500 E Medical Center Dr., Ann Arbor, MI 48109, USA.
ORCID-Profile: Carole A Parent
Förderung
- University of Michigan School of Medicine
- American Heart Association
- National Institute of Health
- T32 training program in Cell and Molecular biology
Zitieren
APA
Collie, S. P., Yu, G., Rawat, S. S., Rypstra, C., & Parent, C. A. (2026). An optimized method to differentiate HL60 cells into neutrophil-like cells. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiag081
Vancouver
Collie SP, Yu G, Rawat SS, Rypstra C, Parent CA. An optimized method to differentiate HL60 cells into neutrophil-like cells. Journal of Leukocyte Biology. 2026. doi:10.1093/jleuko/qiag081
BibTeX
@article{Collie2026,
author = {Collie, Samuel P and Yu, Grant and Rawat, Suraj S and Rypstra, Catharina and Parent, Carole A},
title = {An optimized method to differentiate HL60 cells into neutrophil-like cells},
journal = {Journal of Leukocyte Biology},
year = {2026},
doi = {10.1093/jleuko/qiag081}
}
EUVIMED